Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fluid metabolism" denotes the collective processes that regulate the intake, distribution, and excretion of water and solutes in the body, maintaining internal fluid balance. This process involves an integrated network of sensors (such as baroreceptors and osmoreceptors), hormones (vasopressin/antidiuretic hormone, aldosterone, natriuretic peptides, angiotensin II), and organ systems (particularly the kidneys, hypothalamus, heart, and vasculature)[2][4][6][8]. Disruptions to fluid metabolism underlie conditions such as dehydration, edema, heart failure, and disorders of electrolyte balance. However, fluid metabolism is not a single molecular entity and cannot be targeted as such by drugs or classified as a canonical molecular target. "Fluid metabolism" should be interpreted as a physiological function, *not* a molecule, receptor, or specific therapeutic target. For therapeutic targeting or molecular profiling, focus should be on individual components, such as "Vasopressin receptor 2," "Renin-angiotensin system," "Atrial natriuretic peptide receptor," or specific ion channels and transporters involved in fluid balance[2][4][6][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fluid metabolism.